相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vitro and In Vivo Evaluation of PEGylated Layer-by-Layer Polyelectrolyte-Coated Paclitaxel Nanocrystals
Anna Polomska et al.
SMALL (2017)
Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain glioma
Xiao-li Song et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Design and Synthesis of Near-Infrared Peptide for in Vivo Molecular Imaging of HER2
Bishnu P. Joshi et al.
BIOCONJUGATE CHEMISTRY (2016)
A new peptide ligand for colon cancer targeted delivery of micelles
Yachao Ren et al.
DRUG DELIVERY (2016)
Quantitative analysis of the deposited nanoparticle dose on cell cultures by optical absorption spectroscopy
Anastasia Spyrogianni et al.
NANOMEDICINE (2016)
Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias
Nirali N. Shah et al.
PEDIATRIC BLOOD & CANCER (2016)
Pediatric Sarcomas
Regan F. Williams et al.
SURGICAL CLINICS OF NORTH AMERICA (2016)
The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion
Patricia Jaaks et al.
PLOS ONE (2016)
Novel delivery approaches for cancer therapeutics
Ashim K. Mitra et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target
Gabrielle M. Watson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors
Suraj Dixit et al.
NANOSCALE (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer
Fangfang Wang et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Liposome-supported peritoneal dialysis for detoxification of drugs and endogenous metabolites
Vincent Forster et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel
Li-Min Luo et al.
BIOMATERIALS (2013)
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
Jeffrey A. Silverman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
Susan O'Brien et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Targeted Imaging of Esophageal Neoplasia with a Fluorescently Labeled Peptide: First-in-Human Results
Matthew B. Sturm et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
siRNA Transfection with Calcium Phosphate Nanoparticles Stabilized with PEGylated Chelators
Elisabeth V. Giger et al.
ADVANCED HEALTHCARE MATERIALS (2013)
Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumors
Zhao Yan et al.
ACTA PHARMACOLOGICA SINICA (2012)
Treatment of calcium channel blocker-induced cardiovascular toxicity with drug scavenging liposomes
Vincent Forster et al.
BIOMATERIALS (2012)
Hypoxia enhances cancer cell invasion through relocalization of the proprotein convertase furin from the trans-golgi network to the cell surface
Dominique Arsenault et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Pharmacokinetics and Safety of Marqibo (Vincristine Sulfate Liposomes Injection) in Cancer Patients With Impaired Liver Function
Agop Y. Bedikian et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Development and characterisation of an assay for furin activity
Gemma L. Bourne et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles
Eun Chul Cho et al.
NATURE NANOTECHNOLOGY (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications
Marcin Wysoczynski et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Furin Targeted Drug Delivery for Treatment of Rhabdomyosarcoma in a Mouse Model
Katarina Hajdin et al.
PLOS ONE (2010)
Trends in Childhood Rhabdomyosarcoma Incidence and Survival in the United States, 1975-2005
Simona Ognjanovic et al.
CANCER (2009)
[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model
Ludwig Dubois et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Inhibition of Furin/Proprotein Convertase-catalyzed Surface and Intracellular Processing by Small Molecules
Tomoko Komiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging
Derek W. Bartlett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity
Julia M. Coppola et al.
ANALYTICAL BIOCHEMISTRY (2007)
Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance
M. Kilic et al.
ONCOGENE (2007)
New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?
Si-Shen Feng
NANOMEDICINE (2006)
Furin regulates the intracellular activation and the uptake rate of cell surface-associated MT1-MMP
A. G. Remacle et al.
ONCOGENE (2006)
Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations
MJW Johnston et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic
XB Xiong et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1 - Impact on the bioactivation of proproteins
S McMahon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Folate receptor targeted biodegradable polymeric doxorubicin micelles
HS Yoo et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
RM Schiffelers et al.
JOURNAL OF CONTROLLED RELEASE (2003)
The crystal structure of the proprotein processing proteinase furin explains its stringent specificity
S Henrich et al.
NATURE STRUCTURAL BIOLOGY (2003)
The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis
G Siegfried et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Furin at the cutting edge: From protein traffic to embryogenesis and disease
G Thomas
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods
AM Almeida et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells -: Importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions
AM Khatib et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Hypoxia in human soft tissue sarcomas:: Adverse impact on survival and no association with p53 mutations
M Nordsmark et al.
BRITISH JOURNAL OF CANCER (2001)
Polyarginines are potent furin inhibitors
A Cameron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Rationally designed anti-HER2/neu peptide mimetic disables p185HER2/neu tyrosine kinases in vitro and in vivo
BW Park et al.
NATURE BIOTECHNOLOGY (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
分享论文
